Journal
Frontiers in Immunology
Publication Date
1-1-2023
Volume
13
First Page
1093242
Document Type
Open Access Publication
DOI
10.3389/fimmu.2022.1093242
Rights and Permissions
Goll JB, Bosinger SE, Jensen TL, Walum H, Grimes T, Tharp GK, Natrajan MS, Blazevic A, Head RD, Gelber CE, Steenbergen KJ, Patel NB, Sanz P, Rouphael NG, Anderson EJ, Mulligan MJ and Hoft DF (2023) The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies. Front. Immunol. 13:1093242. doi: 10.3389/fimmu.2022.1093242 © 2023 Goll, Bosinger, Jensen, Walum, Grimes, Tharp, Natrajan, Blazevic, Head, Gelber, Steenbergen, Patel, Sanz, Rouphael, Anderson, Mulligan and Hoft. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Goll, Johannes B; Head, Richard D; and et al., "The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies." Frontiers in Immunology. 13, 1093242 (2023).
https://digitalcommons.wustl.edu/oa_4/2576
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
Corrigendum
